Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
98.4M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
24.5M
-
Shares change
-
+24.5M
-
Total reported value, excl. options
-
$212M
-
Value change
-
+$212M
-
Number of buys
-
50
-
Price
-
$8.87
Significant Holders of Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) as of Q3 2020
50 filings reported holding PSTX - Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2020.
Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.5M shares
of 98.4M outstanding shares and own 24.95% of the company stock.
Largest 10 shareholders include FMR LLC (9.27M shares), Pentwater Capital Management LP (4.88M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.35M shares), BOXER CAPITAL, LLC (1.25M shares), Sectoral Asset Management Inc (1.05M shares), Aisling Capital Management LP (1.04M shares), BlackRock Inc. (955K shares), Vivo Capital, LLC (926K shares), PERCEPTIVE ADVISORS LLC (788K shares), and MILLENNIUM MANAGEMENT LLC (466K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.